NCT02899312View on ClinicalTrials.gov

PSMA PET/CT for Assessment of Recurrent Prostate Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

2,244

Participants

Timeline

Start Date

March 16, 2017

Primary Completion Date

November 30, 2027

Study Completion Date

June 30, 2030

Conditions
Prostatic NeoplasmsProstate Cancer
Interventions
DRUG

PSMA PET/CT scan

"All participants will undergo the same procedures listed in Detailed Description in the protocol section."

Trial Locations (1)

V5Z 4E6

BC Cancer, Vancouver

All Listed Sponsors
lead

British Columbia Cancer Agency

OTHER

NCT02899312 - PSMA PET/CT for Assessment of Recurrent Prostate Cancer | Biotech Hunter | Biotech Hunter